The National Institute for Drug and Food Surveillance (INVIMA) announced the implementation of a new health regulation model with a pro-competitive approach. It seeks to modernize and optimize all of its mission-critical procedures through a structural transformation of its administrative, technological, and management processes.

This change aims to raise standards of quality, efficiency, and transparency, supported by a comprehensive technological platform that will enable 100% online engagement throughout the entire lifecycle of procedures, with automatic or semi-automatic results.

The project aims to strengthen inspection, surveillance, and control functions while facilitating access to records, permits, and health notifications for small, medium-sized, and large companies in the country, promoting a more competitive and agile system.

WHOM DOES IT IMPACT?

The direct impact is felt by national and international companies that require registrations, permits, and health notifications, as well as consumers.

CONCLUSION:

In conclusion, the adoption of INVIMA's new regulatory model represents a high-impact structural change that modernizes health procedures, strengthens surveillance and control, and promotes a more competitive and efficient system, benefiting both regulated companies and the protection of public health.